Walgreens Boots Alliance (NASDAQ:WBA) is a former Dividend Aristocrat that had a 92-year history of paying dividends.
J. M. Smucker is undervalued at a forward PE of 10.7x, offering a solid 4.1% dividend yield with a well-covered 41% payout ratio. Recent performance shows promise with 17% YoY net sales growth and 7% YoY adjusted EPS growth, driven by the Hostess acquisition and key brands like Uncrustables and Jif. Management targets $100 million in annual savings by FY2026, with continued cost synergies and margin improvements expected to bolster earnings.
The market's recent pullback is over. The S&P has hit record highs, driven by strong earnings growth potential through 2027. Despite the S&P 500's historically high PEGY ratio, robust growth forecasts (10%–15% annual EPS through 2026) mean valuations alone won't necessarily trigger a bear market. These 10‐stock dividend aristocrats are 37% undervalued. They offer an average yield of 3.4% and, if they revert to fair value, the potential to deliver up to 78% upside in 2025.
I just upped my position in Realty Income by almost 50%, comfortably making it a top 10 holding in my portfolio. The company looks to have plenty of growth left in the tank. Realty Income continues to possess a sturdy balance sheet and sports a well-covered 6% yield.
Seven Dividend Aristocrats are trading at 52-week lows, but if they return to their historical fair value, they could offer a 34% upside potential in 2025. These aristocrats have strong fundamentals, including a 2.1% yield, A-credit ratings, and an average 41-year dividend growth streak. Historically, these stocks have outperformed the S&P 500 with lower volatility, delivering consistent returns and robust income growth.
Despite market overvaluation, British American Tobacco offers a compelling 8.5% yield and strong long-term growth potential, making it a valuable buy for long-term investors. BTI's fundamentals remain robust. Management and analysts project 13% to 15% CAGR returns, driven by growth in reduced-risk products (RRPs) and strategic share buybacks. Market cycles and valuations constantly revert, presenting opportunities to buy undervalued blue-chip stocks like BTI, which has historically outperformed during market corrections.
These 9 Dividend Aristocrat PEGY bargains offer a 3.1% yield and are trading at a 51% discount to historical PEGY ratios. Analysts project a 55% 12-month upside potential and a 15% CAGR over the next five years, compared to 0% and 9% CAGR for the S&P, respectively. The PEGY ratio, which combines EV/FCF, yield, and growth, identifies undervalued stocks. These stocks offer 12% to 15% CAGR returns and have historically outperformed the S&P 500 with less.
Combining Realty Income with British American Tobacco and Enterprise Products creates a nearly 7% yielding portfolio with a 20% conservative discount to fair value. The $1 Million Retirement Portfolio aims for 34% upside potential and 9% yield, outperforming traditional 60-40 portfolios with 72% less volatility. Concentrated excellence in Ultra SWANs can generate incredible income and Nasdaq-like 12% to 13% annual returns.
**Investment Thesis:** January's top-yielding Aristocrats include Franklin Resources, Realty Income, Amcor, Kenvue, and Hormel, offering dividends from $1K investments exceeding single share prices. **Rating Justification:** Six more Aristocrats could meet the ideal dividend-to-price ratio with a 45.4% market downturn, making them fair-priced investment opportunities. **Analyst Projections:** Top-ten Aristocrats are expected to deliver 22% to 33.36% net gains by January 2025, with an average net gain of 24.96%.
With the possibility of fluctuating interest rates and economic uncertainties, dividend aristocrats stocks like ATO, BRO and CTAS are must-haves for investors in 2025.
Air Products and Chemicals is likely going to boost its dividend payout in January for the 42nd year straight. The company's adjusted EPS jumped in its fiscal fourth quarter. Air Products and Chemicals is a financially sound enterprise.
Cincinnati Financial's stock has surged 30.4% since April 2024, driven by strong Q3 results and a unique equity portfolio strategy. The company reported Q3 diluted EPS of $5.2, with a combined ratio of 97.4%, despite higher catastrophe losses and inflationary pressures. Investment income grew 15% in Q3 2024, with a year-to-date increase of 13%, driven by a robust equity portfolio and stable fixed-income yields.